Medtronic Inc (MDT.N)
55.49USD
1 Aug 2013
$0.25 (+0.45%)
$55.24
$55.34
$55.61
$55.23
1,755,268
1,563,962
$55.89
$38.54
About
Overall
| Beta: | 1.00 |
| Market Cap (Mil.): | $55,654.34 |
| Shares Outstanding (Mil.): | 1,007.50 |
| Dividend: | 0.28 |
| Yield (%): | 2.03 |
Financials
| MDT.N | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | 16.36 | 27.50 | 37.76 |
| EPS (TTM): | 3.38 | -- | -- |
| ROI: | 11.99 | 9.26 | 18.76 |
| ROE: | 19.38 | 12.54 | 19.59 |
UPDATE 1-Medtronic loses heart valve patent fight in Germany
July 12 - A German court ruled against Medtronic Inc in the latest round of its patent fight with Edwards Lifesciences on Friday, judging the U.S. medical device maker's transcatheter heart valve technology infringes a patent owned by Edwards.
Medtronic loses heart valve patent fight in Germany
July 12 - A German court ruled against Medtronic Inc in the latest round of its patent fight with Edwards Lifesciences on Friday, judging the U.S. medical device maker's heart valve technology infringes a patent owned by Edwards.
Medtronic takes 'first step' toward U.S. sale of artificial pancreas
CHICAGO - Type 1 diabetics, who run the risk of dangerously low blood sugar, may be a step closer to getting help from a crude artificial pancreas device that can read blood sugar levels and automatically turn off the flow of insulin after a clinical trial showed the device is safe.
Medtronic takes '1st step' toward U.S. sale of artificial pancreas
CHICAGO, June 22 - Type 1 diabetics, who run the risk of dangerously low blood sugar, may be a step closer to getting help from a crude artificial pancreas device that can read blood sugar levels and automatically turn off the flow of insulin after a clinical trial showed the device is safe.
Medtronic profit beats estimates as international sales jump
- Medical device maker Medtronic Inc reported a better-than-expected quarterly profit, driven by strong international sales, a lower tax rate and demand for new heart stent products, sending its shares up 5 percent in late-morning trading.
Medtronic profit beats estimates as international sales jump
May 21 - Medical device maker Medtronic Inc reported a better-than-expected quarterly profit driven by strong international sales.
Supreme Court agrees to hear Medtronic patent case
WASHINGTON - The U.S. Supreme Court on Monday agreed to hear a patent dispute concerning Medtronic Inc over medical devices it manufactures that give the heart electrical jolts when it fails to pump blood properly.
UPDATE 1-U.S. Supreme Court agrees to hear Medtronic patent case
WASHINGTON, May 20 - The U.S. Supreme Court on Monday agreed to hear a patent dispute concerning Medtronic Inc over medical devices it manufactures that give the heart electrical jolts when it fails to pump blood properly.
U.S. Supreme Court agrees to hear Medtronic patent case
WASHINGTON, May 20 - The U.S. Supreme Court on Monday agreed to hear a patent dispute concerning Medtronic Inc over medical devices it manufactures that give the heart electrical jolts when it fails to pump blood properly.
REFILE-BRIEF-Medtronic says FDA approves longer lengths of Resolute Integrity stent
Feb 25 - Feb 25 - Medtronic Inc : * FDA approves longer lengths of medtronic's resolute integrity stent * FDA approved 34mm,38mm lengths of resolute integrity drug-eluting stent in
Competitors
| Price | Change | |
|---|---|---|
| Olympus Corp (7733.T) | ¥3,075 | +35.00 |
| General Electric Company (GE.N) | $24.62 | +0.25 |
| Siemens AG (SIEGn.DE) | €84.45 | +2.14 |
| Johnson & Johnson (JNJ.N) | $93.77 | +0.27 |
| Roche Holding Ltd. (ROG.VX) | CHF228.00 | -3.50 |
| Abbott Laboratories (ABT.N) | $36.84 | +0.21 |
| Koninklijke Philips NV (PHG.AS) | €24.58 | +0.52 |
| Covidien plc (COV.N) | $62.93 | +1.30 |
| Stryker Corporation (SYK.N) | $71.22 | +0.76 |
| Boston Scientific Corporation (BSX.N) | $11.15 | +0.23 |
Earnings vs.
Estimates
Analyst Research Reports
| Report Title | Price |
|---|---|
|
Provider: Thomson Reuters Stock Report
|
$25.00
|
|
Trading Report for (MDT). A detailed report, including free correlated market analysis, and updates.
Provider: Stock Traders Daily
|
$58.00
|
|
Provider: ValuEngine, Inc.
|
$25.00
|
|
Provider: Stock Traders Daily
|
$495.00
|
|
Provider: Plunkett Research, Ltd.
|
$99.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

